Framingham study insights into hypertensive risk of cardiovascular disease.

Elevated blood pressure is a common and powerful predisposing factor for stroke, coronary disease, cardiac failure and peripheral artery disease imposing a 2-3 fold increased risk of one or more of these atherosclerotic sequelae. The risk ratio imposed by hypertension is greatest for cardiac failure and stroke, but in Western countries coronary disease is the most common and lethal hazard. In hypertensive men and women respectively, 35% and 45% of myocardial infarctions are silent or unrecognized necessitating routine periodic ECG examination for its detection. Comparison of the impacts of systolic and diastolic blood pressure gives no indication of a greater impact of diastolic pressure and isolated systolic hypertension is distinctly hazardous. Over-reliance on diastolic pressure to assess risk can be misleading, particularly in advanced age. Attributable risk estimates suggest that 78% of hypertension in men and 65% in women is directly attributable to adiposity, making weight control of paramount importance for primary prevention of hypertension. The likelihood of development of cardiovascular disease in the hypertensive patient is greatly enhanced by the presence of metabolically-linked risk factors and already existent cardiovascular conditions. These influence the urgency and choice of therapy. Rational and efficient assessment of the hypertensive candidate for cardiovascular disease requires use of a cardiovascular risk profile evaluating the joint effect of multiple risk factors and effective treatment improves multivariate risk.

[1]  S. Manuck,et al.  The Influence of Heart Rate on Coronary Artery Atherosclerosis , 1987, Journal of cardiovascular pharmacology.

[2]  Tobian Lj Interrelationship of sodium, volume, CNS, and hypertension. , 1983 .

[3]  Dustan Hp Role of nutrition in hypertension and its control--experimental aspects. , 1983 .

[4]  L. Wilkins Lowering blood cholesterol to prevent heart disease. NIH Consensus Development Conference Statement. , 1985, Nutrition reviews.

[5]  Jeremiah Stamler,et al.  Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data , 1993 .

[6]  W. Kannel,et al.  Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. , 1987, Preventive medicine.

[7]  P. Wilson,et al.  Factors Associated with Lipoprotein Cholesterol Levels: The Framingham Study , 1983, Arteriosclerosis.

[8]  D. Jacobs,et al.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. , 1989, The New England journal of medicine.

[9]  P. Grøttum,et al.  Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. , 1986, The American journal of cardiology.

[10]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[11]  M. Feinleib On a possible inverse relationship between serum cholesterol and cancer mortality. , 1981, American journal of epidemiology.

[12]  W. Kannel,et al.  High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. , 1983, The American journal of cardiology.

[13]  A. Dyer,et al.  Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. , 1989, JAMA.

[14]  J. Kjekshus Comments — Beta-blockers: Heart rate reduction a mechanism of benefit , 1985 .

[15]  A. Kissebah,et al.  Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .

[16]  M. Weinberger Treatment of hypertension in the 1990s. Optimizing the benefit of blood pressure reduction by minimizing risk factors for cardiovascular disease. , 1987, The American journal of medicine.

[17]  M. Duke Thiazide-lnduced Hypokalemia: Association With Acute Myocardial Infarction and Ventricular Fibrillation , 1978 .

[18]  D L McGee,et al.  Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. , 1981, JAMA.

[19]  E. Ernst,et al.  Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.

[20]  R B D'Agostino,et al.  Determinants of isolated systolic hypertension. , 1988, JAMA.

[21]  Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. , 1971 .

[22]  P. Wilson,et al.  High-density lipoprotein, low-density lipoprotein and coronary artery disease. , 1990, The American journal of cardiology.

[23]  W. Kannel,et al.  Labile Hypertension: A Faulty Concept? The Framingham Study , 1980, Circulation.

[24]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[25]  M. Shipley,et al.  PLASMA LIPIDS AND MORTALITY: A SOURCE OF ERROR , 1980, The Lancet.

[26]  B. Dahlöf,et al.  Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) analyses performed up to 1992. , 1993, Clinical and experimental hypertension.

[27]  K. Anderson,et al.  Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study. , 1991, The American journal of medicine.

[28]  C. Zarins,et al.  Retarding effect of lowered heart rate on coronary atherosclerosis. , 1984, Science.

[29]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[30]  P. Whelton Epidemiology of hypertension , 1994, The Lancet.

[31]  H A Lindberg,et al.  Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. , 1980, American journal of epidemiology.

[32]  J. Feldman,et al.  Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. , 1991, American heart journal.

[33]  J. V. Nixon,et al.  Diuretic-induced ventricular ectopic activity. , 1981, The American journal of medicine.

[34]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[35]  R. Gillum,et al.  The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. , 1988, American heart journal.

[36]  L. Wilkins Nonpharmacological approaches to the control of high blood pressure. Final report of the Subcommittee on Nonpharmacological Therapy of the 1984 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. , 1986, Hypertension.

[37]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[38]  R. D'Agostino,et al.  Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. , 1990, American heart journal.

[39]  W. Kannel,et al.  Declining cardiovascular mortality. , 1984, Circulation.

[40]  W. Kannel,et al.  Lipoproteins, cardiovascular disease, and death. The Framingham study. , 1981, Archives of internal medicine.

[41]  W. Kannel,et al.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.

[42]  J. Hayano,et al.  Decreased magnitude of heart rate spectral components in coronary artery disease. Its relation to angiographic severity. , 1990, Circulation.

[43]  Jeremiah Stamler,et al.  Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. , 1988 .

[44]  W. Kannel,et al.  Unrecognized myocardial infarction and hypertension: the Framingham Study. , 1985, American heart journal.

[45]  W. Kannel,et al.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. , 1984, The New England journal of medicine.

[46]  J. Laragh,et al.  Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. , 1991, The New England journal of medicine.

[47]  R S Paffenbarger,et al.  Heart rate and cardiovascular mortality: the Framingham Study. , 1987, American heart journal.

[48]  A. Hamsten,et al.  Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. , 1992, American heart journal.

[49]  A. P. Haines,et al.  Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. , 1979, British medical journal.